These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 24469037)

  • 1. Structural proteins of Kaposi's sarcoma-associated herpesvirus antagonize p53-mediated apoptosis.
    Chudasama P; Konrad A; Jochmann R; Lausen B; Holz P; Naschberger E; Neipel F; Britzen-Laurent N; Stürzl M
    Oncogene; 2015 Jan; 34(5):639-49. PubMed ID: 24469037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the NEDD8-Activating Enzyme Inhibitor MLN4924 on Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus.
    Chang PJ; Chen LW; Chen LY; Hung CH; Shih YJ; Wang SS
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivation of the p53 pathway as a treatment modality for KSHV-induced lymphomas.
    Sarek G; Kurki S; Enbäck J; Iotzova G; Haas J; Laakkonen P; Laiho M; Ojala PM
    J Clin Invest; 2007 Apr; 117(4):1019-28. PubMed ID: 17364023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Novel Kaposi's Sarcoma-Associated Herpesvirus Orf50 Transcripts: Discovery of New RTA Isoforms with Variable Transactivation Potential.
    Wakeman BS; Izumiya Y; Speck SH
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (KSHV) upregulates survivin expression in KSHV-Associated B-lymphoma cells and contributes to their proliferation.
    Lu J; Verma SC; Murakami M; Cai Q; Kumar P; Xiao B; Robertson ES
    J Virol; 2009 Jul; 83(14):7129-41. PubMed ID: 19439469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
    Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
    J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sirtuin 6 Attenuates Kaposi's Sarcoma-Associated Herpesvirus Reactivation by Suppressing Ori-Lyt Activity and Expression of RTA.
    Hu M; Armstrong N; Seto E; Li W; Zhu F; Wang PC; Tang Q
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30651359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kaposi's Sarcoma-Associated Herpesvirus MicroRNAs Target GADD45B To Protect Infected Cells from Cell Cycle Arrest and Apoptosis.
    Liu X; Happel C; Ziegelbauer JM
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27852859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kaposi's Sarcoma-Associated Herpesvirus Infection Induces the Expression of Neuroendocrine Genes in Endothelial Cells.
    Valiya Veettil M; Krishna G; Roy A; Ghosh A; Dutta D; Kumar B; Chakraborty S; Anju TR; Sharma-Walia N; Chandran B
    J Virol; 2020 Mar; 94(8):. PubMed ID: 31969437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 tumor suppressor protein stability and transcriptional activity are targeted by Kaposi's sarcoma-associated herpesvirus-encoded viral interferon regulatory factor 3.
    Baresova P; Musilova J; Pitha PM; Lubyova B
    Mol Cell Biol; 2014 Feb; 34(3):386-99. PubMed ID: 24248600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kaposi's Sarcoma-Associated Herpesvirus-Encoded circRNAs Are Expressed in Infected Tumor Tissues and Are Incorporated into Virions.
    Abere B; Li J; Zhou H; Toptan T; Moore PS; Chang Y
    mBio; 2020 Jan; 11(1):. PubMed ID: 31911496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kaposi's sarcoma-associated herpesvirus open reading frame 50 represses p53-induced transcriptional activity and apoptosis.
    Gwack Y; Hwang S; Byun H; Lim C; Kim JW; Choi EJ; Choe J
    J Virol; 2001 Jul; 75(13):6245-8. PubMed ID: 11390631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of Kaposi's sarcoma herpesvirus-encoded circular RNAs and a human antiviral circular RNA.
    Tagawa T; Gao S; Koparde VN; Gonzalez M; Spouge JL; Serquiña AP; Lurain K; Ramaswami R; Uldrick TS; Yarchoan R; Ziegelbauer JM
    Proc Natl Acad Sci U S A; 2018 Dec; 115(50):12805-12810. PubMed ID: 30455306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of Kaposi's sarcoma-associated herpesvirus (KSHV) by inhibitors of class III histone deacetylases: identification of sirtuin 1 as a regulator of the KSHV life cycle.
    Li Q; He M; Zhou F; Ye F; Gao SJ
    J Virol; 2014 Jun; 88(11):6355-67. PubMed ID: 24672028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ORF45 Protein of Kaposi Sarcoma-Associated Herpesvirus Is an Inhibitor of p53 Signaling during Viral Reactivation.
    Alzhanova D; Meyo JO; Juarez A; Dittmer DP
    J Virol; 2021 Nov; 95(23):e0145921. PubMed ID: 34523970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complex Interactions between Cohesin and CTCF in Regulation of Kaposi's Sarcoma-Associated Herpesvirus Lytic Transcription.
    Li D; Mosbruger T; Verma D; Swaminathan S
    J Virol; 2020 Jan; 94(2):. PubMed ID: 31666380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. STAT3 Regulates Lytic Activation of Kaposi's Sarcoma-Associated Herpesvirus.
    King CA; Li X; Barbachano-Guerrero A; Bhaduri-McIntosh S
    J Virol; 2015 Nov; 89(22):11347-55. PubMed ID: 26339061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of KAP1 enhances hypoxia-induced Kaposi's sarcoma-associated herpesvirus reactivation through RBP-Jκ.
    Zhang L; Zhu C; Guo Y; Wei F; Lu J; Qin J; Banerjee S; Wang J; Shang H; Verma SC; Yuan Z; Robertson ES; Cai Q
    J Virol; 2014 Jun; 88(12):6873-84. PubMed ID: 24696491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic Herpesvirus Engages Endothelial Transcription Factors SOX18 and PROX1 to Increase Viral Genome Copies and Virus Production.
    Gramolelli S; Elbasani E; Tuohinto K; Nurminen V; Günther T; Kallinen RE; Kaijalainen SP; Diaz R; Grundhoff A; Haglund C; Ziegelbauer JM; Pellinen T; Bower M; Francois M; Ojala PM
    Cancer Res; 2020 Aug; 80(15):3116-3129. PubMed ID: 32518203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCAAT/enhancer-binding protein-alpha is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, and PAN promoters.
    Wang SE; Wu FY; Yu Y; Hayward GS
    J Virol; 2003 Sep; 77(17):9590-612. PubMed ID: 12915572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.